Partner Don Schroeder was quoted in a Society for Human Resource Management (SHRM) article, “New NLRB Acting Chairman May Tilt Board Pro-Business,” covering President Donald Trump’s naming of Philip Miscimarra as acting chairman of the National Labor Relations Board (NLRB) and the agency’s shift toward business interests.
While the Trump administration’s decision to place Miscimarra at the helm of the NLRB marks a change in the agency’s direction, Schroeder notes that dramatic changes will not be seen until the two vacancies left on the board have been filled. Miscimarra will have a say on current cases on the NLRB’s agenda as acting chair, however, Schroeder predicts that the Trump administration will name its nominees within 60 days.
While the Trump administration’s decision to place Miscimarra at the helm of the NLRB marks a change in the agency’s direction, Schroeder notes that dramatic changes will not be seen until the two vacancies left on the board have been filled. Miscimarra will have a say on current cases on the NLRB’s agenda as acting chair, however, Schroeder predicts that the Trump administration will name its nominees within 60 days.
People
Related News
17 January 2025
In the News
Jamie Kuhn's Arrival to Foley Highlighted in Press
Foley & Lardner LLP Public Affairs Director Jamie Kuhn received coverage in legal and business media for her arrival to the firm and strengthening of Foley's bi-partisan government solutions capabilities.
17 January 2025
In the News
Andrew Wronski Weighs in on New Administration's Potential Impact on Manufacturing Sector
Foley & Lardner LLP partner Andrew Wronski is featured for his insights on the incoming presidential administration's impact upon the manufacturing sector in the Milwaukee Business Journal article, "Tariff-ied of the Future?"
15 January 2025
In the News
Marika Miller Shares Insight on DEA's Proposed Special Registration for Telehealth Providers of Controlled Substances
Foley & Lardner LLP attorney Marika Miller shared insight on the U.S. Drug Enforcement Administration's (DEA) proposed special registration process for health care providers prescribing controlled substances via telemedicine in MedPage Today and STAT.